News archive
320 results
-
Updates to the ‘For public’ section
-
Fimeas ICT is doing maintenance work between 3 p.m. and 7 p.m.
-
Travel restrictions speeded up the adoption of remote inspections of pharmacies
-
Pharmaceutical industry operators: The Brexit transition period ends on 31 December 2020
-
Fimea to host the international PIC/S 2020 seminar for GMP inspectors
-
European Medicines Agency endorses use of dexamethasone in COVID-19 patients on supplemental oxygen therapy or on mechanical ventilation
-
Swedish summary of product characteristics for medicines to be provided within a transition period
-
Fimea involved in developing safe cross-border prescription service activities
-
Amendments to pharmaceutical legislation aim to ensure availability and sufficiency of medicines
-
Fimea to open new office in Oulu
-
Fimea reminds marketing authorisation holders to notify shortages in the supply of medicines
-
Act on Secondary Use of Health Data will not be applied to clinical trials
-
A plan for the European medicines regulatory network to safeguard operations in the event of a prolonged corona pandemic
-
Fimea publishes information on granted exemptions starting 1.5.2020
-
Urgent ban on sales, marketing, and distribution of Testerit.fi/Global Network Oy coronavirus rapid test marketed at consumers
-
Ministry of Social Affairs and Health restricts the delivery of asthma medicines to safeguard availability
-
Fimea’s patient advisory board commenced its operations by discussing matters of current interest
-
New Council of Europe resolution will promote pharmaceutical care in Europe
-
Rational use of medicines is promoted through the activities of the National Medicines Information Network
-
Clinical trials during the coronavirus epidemic (COVID-19)
Showing 221 - 240 / 320
